b*y
2 楼
I have been there a few times. Convince yourself that the work is meaningful
regardless where it shows up.
regardless where it shows up.
o*d
4 楼
pat, pat.
Go get a vaccine and re-charge yourself.
Go get a vaccine and re-charge yourself.
a*x
5 楼
go to more conferences and make friends with the editors/potential reviewers
w*e
6 楼
all people in academia are suffered, of course including me.
n*t
7 楼
太普通了,没啥
F*Q
11 楼
暂时还没有。
不过我所说的遭遇并不指这次的事情,这次的事情,老板让我投稿,我已经谢天谢地了。
我所说的遭遇是前面完成的两个课题。一个是写完了初稿,写初稿的时候的结果老板满
意了,但我没满意,因为其中有一个问题不对劲,最后我找到满意的结果后,老板不满
意了,因为结果不支持他以前发表的多篇文章里的结果。他找人检查过我的工作,我的
结果得到了肯定。但老板出于维护面子的立场硬是不让发表我的结果。
另外一个项目是我的结果出来后老板根本就没让写文章,久而久之自己也失去了热情而
没把结果写成文章。这个项目的结果,至今虽然几年过去了,但发PNAS的可能性依然不
小。
::【 在 FAQ (Farmer And Quasiscientist!) 的大作中提到: 】
:: 想想民科的遭遇,你就会舒坦多了。
【在 a*****x 的大作中提到】
: 你后来又投了没?
不过我所说的遭遇并不指这次的事情,这次的事情,老板让我投稿,我已经谢天谢地了。
我所说的遭遇是前面完成的两个课题。一个是写完了初稿,写初稿的时候的结果老板满
意了,但我没满意,因为其中有一个问题不对劲,最后我找到满意的结果后,老板不满
意了,因为结果不支持他以前发表的多篇文章里的结果。他找人检查过我的工作,我的
结果得到了肯定。但老板出于维护面子的立场硬是不让发表我的结果。
另外一个项目是我的结果出来后老板根本就没让写文章,久而久之自己也失去了热情而
没把结果写成文章。这个项目的结果,至今虽然几年过去了,但发PNAS的可能性依然不
小。
::【 在 FAQ (Farmer And Quasiscientist!) 的大作中提到: 】
:: 想想民科的遭遇,你就会舒坦多了。
【在 a*****x 的大作中提到】
: 你后来又投了没?
x*0
13 楼
但是这些最起码证明你自己很有能力很有眼光。
我现在对自己很灰心,觉得很loser. 觉得忙了几年,P也不是。当年还不屑我的同学进
公司,而我要坚持我的理想,现在却成这样。
了。
【在 F*Q 的大作中提到】
: 暂时还没有。
: 不过我所说的遭遇并不指这次的事情,这次的事情,老板让我投稿,我已经谢天谢地了。
: 我所说的遭遇是前面完成的两个课题。一个是写完了初稿,写初稿的时候的结果老板满
: 意了,但我没满意,因为其中有一个问题不对劲,最后我找到满意的结果后,老板不满
: 意了,因为结果不支持他以前发表的多篇文章里的结果。他找人检查过我的工作,我的
: 结果得到了肯定。但老板出于维护面子的立场硬是不让发表我的结果。
: 另外一个项目是我的结果出来后老板根本就没让写文章,久而久之自己也失去了热情而
: 没把结果写成文章。这个项目的结果,至今虽然几年过去了,但发PNAS的可能性依然不
: 小。
:
我现在对自己很灰心,觉得很loser. 觉得忙了几年,P也不是。当年还不屑我的同学进
公司,而我要坚持我的理想,现在却成这样。
了。
【在 F*Q 的大作中提到】
: 暂时还没有。
: 不过我所说的遭遇并不指这次的事情,这次的事情,老板让我投稿,我已经谢天谢地了。
: 我所说的遭遇是前面完成的两个课题。一个是写完了初稿,写初稿的时候的结果老板满
: 意了,但我没满意,因为其中有一个问题不对劲,最后我找到满意的结果后,老板不满
: 意了,因为结果不支持他以前发表的多篇文章里的结果。他找人检查过我的工作,我的
: 结果得到了肯定。但老板出于维护面子的立场硬是不让发表我的结果。
: 另外一个项目是我的结果出来后老板根本就没让写文章,久而久之自己也失去了热情而
: 没把结果写成文章。这个项目的结果,至今虽然几年过去了,但发PNAS的可能性依然不
: 小。
:
h*r
18 楼
pat pat
Take it easy.
Consider the review's comments carefully. And try a again.
Take it easy.
Consider the review's comments carefully. And try a again.
n*k
23 楼
For my main project, at SFN when we presented the study, quite a few asked
me where we had sent--science or nature?...In reality, we started with Cell
(I personally know it is not cell level but we tried anyway:)))...and then
went down the list---luckily/unluckily, it never made through the editors in
any of the top journals...so within 2-3 months, it went to the journal that
eventually accepted the MS and the entirely reviewing process took about 3
months...It is fair to say the study should have faired better at least if
it was from a bull lab...It was a big blow to me and I didn't feel like to
hunt for a job for a big half y until I had to move on...looking back, it
was really hard on me and probably in a short run will hurt my career quite
a bit...nonetheless, the study has drawn much attention from people in the
related research areas. Within half y, there are 9 citations now and I have
received dozens of request for reagents and collaborations...And It was
discussed by SFN forum as well initiated by a postdoc who loved my study so
much---and was surprised that it didn't fair better with the quality and the
amount of the results/data...BTW, faculty of 1000 sucks, my other study
from a top journal got selected but not this much better one...Simply
because of the journals...the same goes with Nature signal transduction
pathway---again my other study was selected as the paper of the month but
this one was not even mentioned anywhere...Anyway, in a sense, you know
your study....not the others esp those shallow editors:))) or trendy
followers....
【在 x*********0 的大作中提到】
: 但是这些最起码证明你自己很有能力很有眼光。
: 我现在对自己很灰心,觉得很loser. 觉得忙了几年,P也不是。当年还不屑我的同学进
: 公司,而我要坚持我的理想,现在却成这样。
:
: 了。
me where we had sent--science or nature?...In reality, we started with Cell
(I personally know it is not cell level but we tried anyway:)))...and then
went down the list---luckily/unluckily, it never made through the editors in
any of the top journals...so within 2-3 months, it went to the journal that
eventually accepted the MS and the entirely reviewing process took about 3
months...It is fair to say the study should have faired better at least if
it was from a bull lab...It was a big blow to me and I didn't feel like to
hunt for a job for a big half y until I had to move on...looking back, it
was really hard on me and probably in a short run will hurt my career quite
a bit...nonetheless, the study has drawn much attention from people in the
related research areas. Within half y, there are 9 citations now and I have
received dozens of request for reagents and collaborations...And It was
discussed by SFN forum as well initiated by a postdoc who loved my study so
much---and was surprised that it didn't fair better with the quality and the
amount of the results/data...BTW, faculty of 1000 sucks, my other study
from a top journal got selected but not this much better one...Simply
because of the journals...the same goes with Nature signal transduction
pathway---again my other study was selected as the paper of the month but
this one was not even mentioned anywhere...Anyway, in a sense, you know
your study....not the others esp those shallow editors:))) or trendy
followers....
【在 x*********0 的大作中提到】
: 但是这些最起码证明你自己很有能力很有眼光。
: 我现在对自己很灰心,觉得很loser. 觉得忙了几年,P也不是。当年还不屑我的同学进
: 公司,而我要坚持我的理想,现在却成这样。
:
: 了。
相关阅读
Gene Ontology分析请教一个概率问题NEED A NAME FOR A PACKAGE--5 baozi for the one I choose as favorite形势在变好?(zz)这个....kinase 底物,S-D有表型,S-A没有表型?Nobel Prize for chemistry 2013生物男指点江山:匪夷所思的跨界求审稿:cell biology, developmental biology, tissue engineWho's Afraid of Peer Review?风险投资/ 风投 (Venture Capital / VC)11工真是擦肩了cancer mutation的AA和碱基的对应别人能用我的data申请 K99 吗?苦逼的Oracle学员面试回忆录和录音,绝对真实!供想入行Oracle的博士潜露露,露露陈是不是代表了当今70,80后中国生物女进军生物的生物转行群 18221066Immediate opening: Regeneron master level biochemist (转载)大家觉得传统的基因打靶方法是否就要被彻底取代了求推荐制备抗体的公司